Indefinite Delivery Contract SPE2DB20D9759

This is a $499,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, issued under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities nationwide.

The task orders issued under this IDC cover a diverse portfolio of pharmaceutical items such as Nexplanon, Mirena, Xolair, Botox, and various generic medications. The delivery orders are predominantly awarded as firm fixed-price contracts, without any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. Through this IDC and associated task orders, DMS Pharmaceutical Group is positioned as a crucial supplier in the federal pharmaceutical supply chain, providing essential prescription drugs and medical supplies to Department of Defense healthcare sites.